When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CDTX - Cidara Therapeutics' rezafungin prophylaxis development program nabs QIDP and Fast Track designations
Cidara Therapeutics Inc.
The FDA grants Qualified Infectious Disease Product (QIDP) and Fast Track designations for Cidara Therapeutics' (CDTX) prophylaxis (prevention) development program for lead antifungal product candidate, rezafungin for injection.
More news on: Cidara Therapeutics, Healthcare stocks news,